DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Aricept (Donepezil Hydrochloride) - Summary

 

-- advertisement --

ARICEPT SUMMARY

ARICEPT® (donepezil hydrochloride) is a reversible inhibitor of the enzyme acetylcholinesterase.

ARICEPT® is indicated for the treatment of mild to moderate dementia of the Alzheimer's type.

ARICEPT NEWS HIGHLIGHTS

Media Articles Related to Aricept (Donepezil)

ARICEPT (Donepezil) effective for severe Alzheimer's disease
Source: The Doctors Lounge - Neurology

New Alzheimer's Disease Survey Reveals Disparities Between Beliefs And Behavior In Pursuing Diagnosis
Source: Seniors / Aging News From Medical News Today [2008.09.25]

Alzheimer's Disease and Sundowning: A Caregivers' Challenge
Source: MedicineNet Dementia Specialty [2008.09.05]

Alzheimer's Disease: Home Safety Information
Source: MedicineNet Advance Medical Directives Specialty [2008.08.26]

Alzheimer's Disease Patient Caregiver Guide
Source: MedicineNet Dehydration Specialty [2008.08.26]

more>>

Published Studies Related to Aricept (Donepezil)

Randomized double-blind placebo-controlled donepezil augmentation in antidepressant-treated elderly patients with depression and cognitive impairment: a pilot study. [2008.07]

Effects of donepezil on verbal memory after semantic processing in healthy older adults. [2008.06]

Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial. [2008.05]

Donepezil improves obstructive sleep apnea in Alzheimer disease: a double-blind, placebo-controlled study. [2008.03]

Effects of galantamine on measures of attention: results from 2 clinical trials in Alzheimer disease patients with comparisons to donepezil. [2008.01]

more>>

Clinical Trials Related to Aricept (Donepezil)

Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer’s Disease [Completed]

A Study of the Efficacy and Safety of Aricept in Patients With Severe Alzheimer's Disease Who Are Living in Skilled Nursing Homes [Completed]

Vaspect Study - An Open-Label Trial Of Donepezil in Vascular and Mixed Dementia [Completed]

EARTH 413: A Study of Aricept in Hispanic Patients With Mild to Moderate Alzheimer's Disease (AD) [Completed]

Aricept to Improve Functional Tasks in Vascular Dementia [Recruiting]

more>>

Page last updated: 2008-09-25

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008